NeuroSense Therapeutics Ltd.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-1.5M | $-1.6M | $17.0K | $1.8M |
| FY2022 | $-7.6M | $-7.7M | $70.0K | $1.7M |
| FY2023 | $-8.4M | $-8.4M | $29.0K | $1.5M |
| FY2024 | $-10.1M | $-10.1M | $3.0K | $557.0K |
| FY2025 | $-7.7M | $-7.7M | $8.0K | $2.1M |